drugset / Trial / NCT01769885

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

NCT01769885

NaSingle-groupOpen-labelTreatment

Summary

This clinical trial studies tivozanib before surgery in treating patients with localized kidney cancer. Tivozanib may stop the growth of tumor cells by blocking some of the growth factors needed for cell growth.

Timeline

Start
2013-03-14
Primary completion
2013-06-14
Completion
2013-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tivozanib Small molecule Oral

Indications